期刊文献+

膝关节周围骨巨细胞瘤病理性骨折影像学特征研究 被引量:13

Radiological features about pathological fracture of giant cell tumor around the knee joint
原文传递
导出
摘要 目的比较膝关节周围骨巨细胞瘤(giantcelltumor,GCT)无病理性骨折与病理性骨折患者的影像学差异,探讨病理性骨折的影像学特征。方法2000年3月至2013年12月,天津医院、第四军医大学附属西京医院、济南军区总医院、浙江大学医学院第二附属医院、四川大学附属华西医院等国内五家骨肿瘤治疗中心的膝关节周围GCT病例91例,男40例(44.0%),女51例(56.0%);年龄17-78岁,平均36.81岁。分为无病理性骨折组(53例)和病理性骨折组(38例)。分析两组病例影像学资料中的肿瘤体积、肿瘤到软骨下骨的距离、Campanacci分级、软组织侵袭情况及病理性骨折移位情况等指标间的差异。结果20-40岁年龄段的GCT患者所占比例最高(58.2%,53/91)。GCT位于股骨远端的比例病理性骨折组(78.9%)高于无病理性骨折组(45.3%),差异有统计学意义(χ^2=10.40,P=0.001);病理性骨折组的肿瘤体积[(98.46±53.35)cm]大于无病理性骨折组[(63.19±34.92)cm],差异有统计学意义(t=3.57,P=0.001);病理性骨折组肿瘤到关节面的距离(中位数:0.145am;极差:0.46cm)小于无病理性骨折组(中位数:0.170cm;极差:1.90cm),差异有统计学意义(χ^2=2.853,P=0.004)。软组织受侵袭不同程度在病理性骨折发生率上差异有统计学意义(χ^2=11.08,P=0.004)。结论膝关节周围GcT肿瘤体积大小、肿瘤到软骨下骨的距离及软组织受侵袭程度均与病理性骨折的发生有密切关系。 Objective To compare the radiological differences of giant cell tumor (GCT) around the knee between those with pathological fracture and those without pathologic fracture and explore the radiological features of pathological fracture. Methods From March 2000 to December 2013, 91 patients with GCT around the knee from domestic five bone tumor centers were involved, including 40 males and 51 females, with an average age of 36.81 years (range, 17-78). All patients were divided in- to non pathological fracture group (53 cases) or pathological fracture group (38 cases). The radiological differences such as tumor volume, the distance between tumor and subchondral bone, Campanacci classification, soft tissue invasion and bone displacement were analyzed. Results GCT most frequently occurred in young adults between 20 and 40 years of age (58.2%, 53/91), pathologi- cal fracture group with 78.9%. The proportion of tumors on the distal femur of pathological fracture group was higher than the non pathological fracture group, which showed statistical significance (χ^2=10.40, P=0.001). The tumor volume of pathological fracture group [(98.46±53.35) cm^3] was greater than the no pathological fracture group [(63.19+34.92) cm^3], there was statistical differ- ence between the two groups (t=3.57, P=0.001). The distance between tumor and subchondral bone of pathological fracture group [median (M)= 0.145 cm, range (R)=0.46 cm] was lower than that non pathological fracture group (M, 0.170 cm; R, 1.90 cm), and the difference was statistically significant (χ^2=2.853, P=0.004). There were also significant differences in the incidence of patholog- ic fracture between the degree of soft tissue invasion (χ^2=11.08, P=0.004). Conclusion Tumor volume, distance between tumor and subchondral bone and the dezree of soft tissue invasion are closelv related to natholozical fracture of GCT around the knee.
出处 《中华骨科杂志》 CAS CSCD 北大核心 2014年第5期564-571,共8页 Chinese Journal of Orthopaedics
基金 天津市自然科学基金面上项目(12JCYBJC16400) 天津市卫生局科技基金重点项目(12KG121)
关键词 膝关节 骨巨细胞瘤 骨折 自发性 放射摄影术 Knee joint Giant cell tumor of bone Fractures, spontaneous Radiography
  • 相关文献

参考文献24

  • 1Klenke FM,Wenger DE,Inwards CY,et al.Giant cell tumor of bone:risk factors for recurrence[J].Clin Orthop Relat Res,2011,469(2):591-599.
  • 2van der Heijden L,Dijkstra PDS,Campanacci DA,et al.Giant cell tumor with pathologic fracture:should we curette or resect[J]?Clin Orthop Relat Res,2013,471(3):820-829.
  • 3Dreinhofer KE,Rydholm A,Bauer HC,et al.Giant-cell tumours with fracture at diagnosis.Curettage and acrylic cementing in ten cases[J].J Bone Joint Surg Br,1995,77(2):189-193.
  • 4Von Steyern FV,Kristiansson I,Jonsson K,et al.Giant-cell tumour of the knee:the condition of the cartilage after treatment by curettage and cementing[J].J Bone Joint Surg Br,2007,89(3):361-365.
  • 5Alkalay D,Kollender Y,Mozes M,et al.Giant cell tumors with intraarticular fracture Two-stage local excision,cryosurgery and cementation in 5 patients with distal femoral tumor followed for 2-4 years[J].Acta Orthop Scand,1996,67(3):291-294.
  • 6Jeys LM,Suneja R,Chami G,et al.Impending fractures in giant cell tumours of the distal femur:incidence and outcome[J].Int Orthop,2006,30(2):135-138.
  • 7Miller G,Bettelli G,Fabbri N,et al.Curettage of giant cell tumor of bone.Introduction--material and methods[J].Chir Organi Mov,1989,75(1 Suppl):S203.
  • 8Szendr(o)i M.Giant-cell tumour of bone[J].J Bone Joint Surg Br,2004,86(1):5-12.
  • 9Huber M,Gerber C.Fracture due to primary tumours and tumourlike changes[J].Unfallchirurg,1990,93(10):438-448.
  • 10G(o)bel V,Jürgens H,Etspüler G,et al.Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents[J].J Cancer Res Clin Oncol,1987,113(2):187-191.

二级参考文献90

  • 1Shin KH,Moon SH,Suh JS,et al.Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma.Clin Orthop Relat Res,2000(376):200-208.
  • 2Bieling P,Rehan N,Winkler P,et al.Tumor size and prognosis in aggressively treated osteosarcoma.J Clin Oncol,1996,14(3):848-858.
  • 3Shih HN,Shih LY,Cheng CY,et al.Reconstructing humerus de fects after tumor resection using an intramedullary cortical allo graft strut.Chang Gung Med J,2002,25(10):656-663.
  • 4Hirn M,de Silva U,Sidharthan S,et al.Bone defects following curettage do not necessarily need augmentation.Acta Orthop,2009,80(1):4-8.
  • 5Yanagawa T,Watanabe H,Shinozaki T,et al.Curettage of benign bone tumors without grafts gives sufficient bone strength.Acta Orthop,2009,80(1):9-13.
  • 6Jeys LM,Suneja R,Chami G,et al.Impending fractures in giant cell tumours of the distal femur:incidence and outcome.Int Orthop,2006,30(2):135-138.
  • 7Holscher HC,Bloem JL,van der Woude HJ,et al.Can MRI pre dict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy.Clin Radiol,1995,50(6):384-390.
  • 8Bacci G,Longhi A,Versari M,et al.Prognostic factors for os teosarcoma of the extremity treated with neoadjuvant chemothera py:15-year experience in 789 patients treated at a single institution.Cancer,2006,106(5):1154-1161.
  • 9G(o)bel V,Jtrgens H,Etspüler G,et al.Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents.J Cancer Res Clin Oncol,1987,113 (2):187-191.
  • 10Prosser GH,Baloch KG,Tillman RM,et al.Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? Clin Orthop Relat Res,2005 (435):211-218.

共引文献57

同被引文献132

  • 1于秀淳,刘晓平,周银,王永惕.原发恶性骨巨细胞瘤11例临床病理分析[J].临床肿瘤学杂志,1997,2(1):25-28. 被引量:2
  • 2张芳,朱荣广,张茹.手足骨骨巨细胞瘤的X线诊断(附15例报告)[J].滨州医学院学报,2005,28(6):464-465. 被引量:3
  • 3杨正明,陶惠民,杨迪生,叶招明,李伟栩.邻膝关节骨巨细胞瘤外科治疗的选择[J].中华外科杂志,2006,44(24):1693-1698. 被引量:22
  • 4郭卫,杨毅,李晓,姬涛.四肢骨巨细胞瘤的外科治疗[J].中华骨科杂志,2007,27(3):177-182. 被引量:34
  • 5杜联军,丁晓毅,颜凌,陆勇,刘晓薇,江浩,陈克敏.骨巨细胞瘤常见和典型的CT表现分析[J].实用放射学杂志,2007,23(8):1070-1073. 被引量:17
  • 6Fraioli MF, Lecce M, Fraioli C, et al. Spinal giant cell tumor in tuberous sclerosis : case report and review of the literature [ J ]. J Spinal Cord Med, 2013, 36:157-160.
  • 7Pina S, Fernandez M, Maya S, et al. Recurrent temporal bone tenosynovial giant cell tumor with chondroid metaplasia : the use of imaging to assess recurrence [ J ]. Neuroradiol J, 2014, 27 : 97-101.
  • 8Boons HW, Keijser I,C, Sehreuder HW, et al. Oncologic. and tilnc- tional results after treatment of giant cell tumors of bone [ J ]. Arch Orthop Trauma Surg, 2002, 122(1): 17-23.
  • 9Karpik M. Giant Cell Tumor (tumor gigantocellularis, osteoclaslo- ma) - epidemiolo', diagnosis, treatment [J ]. Ortop Traumalol Re-habil, 2010, 12(3): 207-215.
  • 10Trieb K, Bitzan P, Lang S, et al. Recurrence of curetted and bone- grafted giant-cell tumours with and without adjuvant phenol thera- py[J]. Eur J Surg Oncol, 2001, 27(2): 200-202.

引证文献13

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部